CIK 0000749647
- Non-accelerated filer
- Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521256615
- Phone
- +1 609-896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,950
- in 1 filing
Net −$3,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +12,500 | 228,346 | ||
| 2024-03-15 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 33,599 | ||
| 2024-03-15 | Braun Donald P Director | Grant or award · Option to purchase Imunon common stock | +3,500 | 19,930 | ||
| 2024-03-15 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 14,166 | ||
| 2024-03-15 | Lindborg Stacy Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 14,166 | ||
| 2024-03-15 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 9,167 | ||
| 2024-03-14 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-12-07 | Hazard Sebastien Chief Medical Officer | Grant or award | +20,000 | 20,000 | ||
| 2023-12-07 | Hazard Sebastien Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2023-03-17 | Braun Donald P Director | Grant or award · Option to purchase Imunon common stock | +2,000 | 16,430 | ||
| 2023-03-17 | Chow Pok Yu Augustine Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 18,429 | ||
| 2023-03-17 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 30,099 | ||
| 2023-03-17 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 9,666 | ||
| 2023-03-17 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 4,667 | ||
| 2023-03-17 | Lindborg Stacy Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 9,666 | ||
| 2023-03-17 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +25,000 | 215,846 | ||
| 2023-03-17 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 85,688 | ||
| 2023-03-17 | CHURCH JEFFREY WAYNE CFO | Grant or award · Stock Option (Right to Buy) | +40,000 | 95,950 | ||
| 2023-03-17 | Le Goff Corinne President and CEO | Grant or award · Stock Option (Right to Buy) | +90,000 | 320,000 | ||
| 2022-09-30 | Dentzer James E Director | Grant or award · Option (right to buy) | +2,667 | 2,667 |
Page 7 of 12 · 240 trades